Carotid Revascularization in the Era of Modern Medical Therapy: Is Urgency Still Justified?
Calvin D. De Louche, Alun H. Davies · 2026
Read Carotid Revascularization in the Era of Modern Medical Therapy: Is Urgency Still Justified? by Calvin D. De Louche, Alun H. Davies (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13549611.txt.
Description
A peer-reviewed research article from Europe PMC (2026). (CEA) can often be planned and delivered selectively, and that OMT alone may be reasonable for some lower-risk groups until trial evidence matures. The timing calculus may differ for transfemoral carotid artery stenting (TF-CAS) and transcarotid artery revascularization (TCAR) because of different antiplatelet requirements and procedural risk profiles, but the central principle remains the same: treat medically now, then revascularize selectively when residual risk justifies it.
Catalog record
| CREATOR | Calvin D. De Louche, Alun H. Davies |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |